The pharmacology of anticonvulsant drugs.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D001711:Biotransformation; D001921:Brain / Q000503:physiopathology; D004195:Disease Models, Animal; D004558:Electric Stimulation; D004734:Energy Metabolism / Q000187:drug effects; D004827:Epilepsy / Q000188:drug therapy; D005492:Folic Acid / Q000378:metabolism; D000882:Haplorhini; D006801:Humans; D006859:Hydrogen / Q000378:metabolism; D008564:Membrane Potentials / Q000187:drug effects; D051379:Mice; D009474:Neurons / Q000187:drug effects; D018377:Neurotransmitter Agents; D010215:Papio; D011188:Potassium / Q000378:metabolism; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D012964:Sodium / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects
D000927:Anticonvulsants; D018377:Neurotransmitter Agents; D006859:Hydrogen; D005492:Folic Acid; D012964:Sodium; D011188:Potassium